相关实验视频
Updated: Sep 14, 2025

06:02
Detection of Neuritic Plaques in Alzheimer's Disease Mouse Model
Published on: July 26, 2011
36.8K
对于阿尔茨海默病,他类药物的保护作用
Leila Rezakhani1,2, Zahra Salimi1,3, Fatemeh Zarei4
1Fertility and Infertility Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Ewha medical journal
|July 24, 2025
概括
用于降低胆固醇的他类药物,通过减少粉样β斑块并提供神经保护作用,在预防阿尔茨海默病 (AD) 中表现有前途. 这些降胆固醇药物还具有抗氧化和抗炎性质,有利于AD治疗.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 老年学是一门学科.
背景情况:
- 阿尔茨海默病 (AD) 是一种流行的神经退行性疾病,影响全球超过2000万人,其特点是认知能力下降.
- 阿尔茨海默病的主要病理特征包括粉样β (Aβ) 斑块和神经纤维状结 (NFT).
- 胆固醇水平升高与阿尔茨海默病风险增加有关,这表明胆固醇管理作为治疗策略.
研究的目的:
- 审查他类药物对阿尔茨海默病的神经保护作用.
- 探索除了降低胆固醇之外,他类药物的多方面的治疗特性.
主要方法:
- 对调查他类药物和阿尔茨海默病的研究进行文献综述.
- 对他类药物对Aβ病理,氧化应激,神经炎症和突触功能影响的分析.
主要成果:
- 类药物有效降低LDL胆固醇,并且已知可以减少Aβ病理.
- 除了降低胆固醇之外,他类药物表现出显著的抗氧化,抗炎和神经保护作用.
- 这些类他类药物的性作用有助于它们在AD等神经退行性疾病中的潜在治疗作用.
结论:
- 类药物通过胆固醇依赖和独立的机制证明了对阿尔茨海默病的保护作用.
- 类药物的抗氧化,抗炎和神经保护性质支持在AD治疗和预防策略中考虑它们.
- 对他类药物在治疗阿尔茨海默病的有效性进行进一步的研究是有必要的.
相关概念视频
Alzheimer's Disease: Treatment
262
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
262
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
875
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
875
Alzheimer's Disease: Overview
669
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
669
Atherosclerosis III: Management
35
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
35
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
208
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
208
Cholesterol: Significance and Regulation
689
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
689

